Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9R6L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,638
Award facts
- Contract value 100% obligated
- $23,638.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Zepbound (semaglutide) 5 mg/0.5 mL pen injections. This firm fixed-price delivery order carries a ceiling value of $23,638.21 and is scheduled for completion by January 30, 2026. The award was made on a competitive basis with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 through December 2026 and serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs with an extensive portfolio spanning multiple therapeutic domains including specialty medications, brand-name and generic drugs, and medical supplies. The company's parent organization, Cencora, Inc., holds the primary IDC with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. This delivery order for Zepbound demonstrates AmerisourceBergen's ongoing capability to efficiently fulfill government pharmaceutical supply requirements for military treatment facilities and other federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26F9R6L?
SPE2DR26F9R6L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F9R6L worth?
The government has obligated $23,638 on SPE2DR26F9R6L.
Is contract SPE2DR26F9R6L an order under another contract?
Yes. SPE2DR26F9R6L is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9R6L competed?
The extent of competition for SPE2DR26F9R6L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award